Sponsor Pipeline

Halda Therapeutics OpCo, Inc. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
2
Active Trials
2
Recruiting
2
Disease Areas
2
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-07-26 NCT07524855
A Study of HLD-0117 in Patients With Metastatic Breast Cancer		 Sponsor changed: Halda Therapeutics OpCo, Inc. -> Janssen Research & Development, LLC
2026-07-26 NCT06800313
Study of HLD-0915 in Patients With Metastatic Prostate Cancer		 Sponsor changed: Halda Therapeutics OpCo, Inc. -> Janssen Research & Development, LLC
Active Trials by Phase
Phase 1/2
1
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 1/2
NCT06800313 Study of HLD-0915 in Patients With Metastatic Prostate Cancer Metastatic Prostate Cancer Recruiting
Phase 1
NCT07524855 A Study of HLD-0117 in Patients With Metastatic Breast Cancer Metastatic Breast Cancer Recruiting
Disease Areas
Prostate Cancer (1) Breast Cancer (1)
Get alerts when Halda Therapeutics OpCo, Inc.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free